Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Patient-reported outcomes from a single-centre prospective post-marketing study on Collagenase Clostridium Histolyticum injections for Peyronie's disease

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Effect of bipolar radiofrequency thermotherapy on benign prostate hyperplasia

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Anogenital distance and reproductive parameters in young men

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. A novel double staining strategy for improved detection of testicular carcinoma in situ cells in human semen samples

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The sperm penetration test (P-test) can predict fecundability in the male partner from infertile couples.

    Research output: Contribution to journalJournal articleResearch

  5. Prolactin and pituitary-gonadal function in cigarette smoking infertile patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Male Circumcision Complications - A systematic review, meta-analysis and meta-regression

    Research output: Contribution to journalReviewResearchpeer-review

  2. Evaluation of a re-engineered device for penile vibratory stimulation in men with spinal cord injury

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Udredning og behandling af mandlig infertilitet

    Research output: Contribution to journalReviewResearchpeer-review

  4. Scheduling appointments for postvasectomy semen analysis has no impact on compliance

    Research output: Contribution to journalJournal articleResearchpeer-review

  • CopMich Collaborative
View graph of relations

The aim of this study was to evaluate patient-reported outcomes of Collagenase Clostridium Histolyticum (CCHi) for Peyronie's Disease. Patients treated with 2-4 cycles of CCHi between 01/2016 and 08/2018 were asked to fill out the "bother domain" of the Peyronie's Disease Questionnaire (PDQ) at scheduled appointments for injections. CCHi cycles involved two injections (0.58 mg) separated by 48-72 hr. During the study, 34 patients were treated, seven patients were excluded due to incomplete baseline values. Mean (standard deviation) PDQ bother domain baseline score was 11.1 (2.6). ANOVA demonstrated statistically significant effects of injections (p < .001) with a decrease in PDQ bother domain scores 6 weeks after the 1st cycle (9.9 [3.3], p = .013), 6 weeks after the 2nd cycle (8.2 [4.0], p = .009) and 6 weeks after the 3rd cycle (6.5 [3.6], p < .001). After 2-4 cycles of CCHi treatment, patients reported changes in penile curvature as "Worse" (0), "No Change" (2), "Little decrease" (10), Decrease (10) and "Significant decrease" (4). After completion of CCHi treatment, 82% of patients still reported that vaginal intercourse was difficult or impossible. Patients with Peyronie's Disease undergoing CCHi treatment reported statistically significant decreases in PDQ bother domain scores. However, most patients still report difficulty with intercourse after treatment.

Original languageEnglish
JournalAndrologia
Volume52
Issue number10
Pages (from-to)e13733
ISSN0303-4569
DOIs
Publication statusPublished - Nov 2020

ID: 62393290